The emergence of the drug receptor theory
Open accessThe DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Abstract
Today, the concept of specific receptors for drugs and transmitters lies at the very heart of pharmacology. Less than one hundred years ago, this novel idea met with considerable resistance in the scientific community. To mark the 150th anniversary of the birth of John Newport Langley, one of the founders of the receptor concept, we highlight his most important observations, and those of Paul Ehrlich and Alfred Joseph Clark, who similarly helped to establish the receptor theory of drug action.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
A STUDY OF THE ADRENOTROPIC RECEPTORS
Ahlquist, R. P. (1948) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1948.153.3.586 · Cited by 2,893
Dictionary of Scientific Biography
Miller, S. T. (1981) · Reference Services Review · doi:10.1108/eb048704 · Cited by 2,405
LANGLEY, J. N. (1903) · Brain · doi:10.1093/brain/26.1.1 · Cited by 1,656
Dictionary of Scientific Biography.
(1974) · Isis · doi:10.1086/351266 · Cited by 1,387
Chemical structure and sympathomimetic action of amines
Barger, G., & Dale, H. H. (1910) · The Journal of Physiology · doi:10.1113/jphysiol.1910.sp001392 · Cited by 726
Langley, J. N. (1905) · The Journal of Physiology · doi:10.1113/jphysiol.1905.sp001128 · Cited by 602
The Collected Papers of Paul Ehrlich
(2013) · Elsevier eBooks · doi:10.1016/c2013-0-01635-0 · Cited by 365
The response of a single end organ
Matthews, B. H. C. (1931) · The Journal of Physiology · doi:10.1113/jphysiol.1931.sp002718 · Cited by 317
The Rate of Action of Drugs on Cells
Clark, A. J. (1937) · General Pharmacology · doi:10.1007/978-3-642-80555-4_13 · Cited by 315
A Manual of Pharmacology and Its Applications to Therapeutics and Toxicology
(1948) · Journal of the American Medical Association · doi:10.1001/jama.1948.02890460089027 · Cited by 238
Research works printed but not linked: 13
- Bickel, M. H. Die Entwicklung zur experimentellen Pharmakologie 1790–1850: Wegbereiter von Rudolf Buchheim (Schwabe, Basel, 2000).
- Stille, G. Der Weg der Arznei von der Materia Medica zur Pharmakologie: Der Weg von Arzneimittelforschung und Arzneitherapie (G. Braun Fachverlage, Karlsruhe, 1994).
- Langley, J. N. On the physiological action of jaborandi. Proc. Camb. Phil. Soc. April, 402–404 (1875).
- Goldsmith, M. in Twelve Jews (ed. Bolitho, H) 65–81 (Rich & Cowan, London, 1934).
- Bäumler, E. Paul Ehrlich. Forscher für das Leben 3rd edn (Edition Wötzel, Frankfurt/Main, 1997).
- Ehrlich, P. in The Collected Papers of Paul Ehrlich in Four Volumes Including a Complete Bibliography. Vol. I Histology, Biochemistry and Pathology (English translation) (ed. Himmelweit, F) 433–496 (Pergamon, London, 1956).
- Ehrlich, P. & Morgenroth, J. The Collected Papers of Paul Ehrlich in Four Volumes Including a Complete Bibliography. Vol. II Immunology and Cancer Research (English translation) (ed. Himmelweit, F) 278–297 (Pergamon, London, 1957).
- Ehrlich, P. & Sachs, H. The Collected Papers of Paul Ehrlich in Four Volumes Including a Complete Bibliography. Vol. II Immunology and Cancer Research (ed. Himmelweit, F) 432–441 (Pergamon, London, 1957).
- Ehrlich, P. in The Collected Papers of Paul Ehrlich in Four Volumes Including a Complete Bibliography. Vol. II Immunology and Cancer Research (ed. Himmelweit, F) 298–315 (Pergamon, London, 1957).
- Langley, J. N. Nouvelles observations sur la nature non-spécifique des terminaisons nerveuses motrices et sur l'existence de radicules 'réceptives' dans le muscle. Arch. Int. Physiol. 5, 115–118 (1907).
- Traube, I. Die physikalische Theorie der Arzneimittel — und Giftwirkung. Biochem. Ztschr. 98, 177–196 (1919).
- Martius, F. Das Arndt-Schulzsche Grundgesetz. Münchener Med. Wschr. 70, 1005–1006 (1923).
- Back, M.-L. Die Entwicklung des Freiburger Pharmakologischen Instituts 1907–1923 Thesis, Univ. Freiburg (1986).
Cited by
Principles: Receptor theory in pharmacology
Kenakin, T. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.02.012 · Cited by 412
Antisense technology: A review
Crooke, S. T., Liang, X.-H., Baker, B. F., & Crooke, R. M. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100416 · Cited by 326
Rediscovering the sweet spot in drug discovery
Brown, D., & Superti-Furga, G. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02902-7 · Cited by 176
Time‐scale separation – Michaelis and Menten's old idea, still bearing fruit
Gunawardena, J. (2013) · FEBS Journal · doi:10.1111/febs.12532 · Cited by 150
Ecological Roles and Biological Activities of Specialized Metabolites from the GenusNicotiana
Jassbi, A. R., Zare, S., Asadollahi, M., & Schuman, M. C. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00001 · Cited by 122
New drug discovery and development from natural products: Advances and strategies
Wang, Y., Wang, F., Liu, W., Geng, Y., Shi, Y., Yu, T., Zhang, B., Luo, Y., & Sun, X. (2024) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2024.108752 · Cited by 112
The clinical analgesic efficacy of buprenorphine
Raffa, R. B., Haidery, M., Huang, H.-M., Kalladeen, K., Lockstein, D. E., Ono, H., Shope, M. J., Sowunmi, O. A., Tran, J. K., & Pergolizzi, J. V. (2014) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/jcpt.12196 · Cited by 105
Free Drug Theory – No Longer Just a Hypothesis?
Summerfield, S. G., Yates, J. W. T., & Fairman, D. A. (2022) · Pharmaceutical Research · doi:10.1007/s11095-022-03172-7 · Cited by 106
Polypharmacology in Precision Oncology: Current Applications and Future Prospects
Antolín, A. A., Workman, P., Mestres, J., & Al‐Lazikani, B. (2016) · Current Pharmaceutical Design · doi:10.2174/1381612822666160923115828 · Cited by 111
The Pharmacophore Concept and Its Applications in Computer-Aided Drug Design
Seidel, T., Schuetz, D. A., Garon, A., & Langer, T. (2019) · Fortschritte der Chemie Organischer Naturstoffe/Fortschritte der Chemie organischer Naturstoffe/Progress in the chemistry of organic natural products · doi:10.1007/978-3-030-14632-0_4 · Cited by 96
Systems pharmacology and genome medicine: a future perspective
Wist, A. D., Berger, S., & Iyengar, R. (2009) · Genome Medicine · doi:10.1186/gm11 · Cited by 95
Nongenetic engineering strategies for regulating receptor oligomerization in living cells
Li, J., Wang, L., Tian, J., Zhou, Z.-L., Li, J., & Yang, H. (2020) · Chemical Society Reviews · doi:10.1039/c9cs00473d · Cited by 75
Medicinal Chemistry and the Pharmacy Curriculum
Khan, M. O. F., Deimling, M. J., & Philip, A. (2011) · American Journal of Pharmaceutical Education · doi:10.5688/ajpe758161 · Cited by 74
100 years of modelling ligand–receptor binding and response: A focus on GPCRs
Finlay, D. B., Duffull, S. B., & Glass, M. (2020) · British Journal of Pharmacology · doi:10.1111/bph.14988 · Cited by 79
Automated docking for novel drug discovery
Bello, M., Martínez‐Archundia, M., & Correa‐Basurto, J. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.794780 · Cited by 76
Discovering risperidone: the LSD model of psychopathology
Colpaert, F. C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1062 · Cited by 78
Screening the receptorome: an efficient approach for drug discovery and target validation
Strachan, R. T., Ferrara, G., & Roth, B. L. (2006) · Drug Discovery Today · doi:10.1016/j.drudis.2006.06.012 · Cited by 74
Imaging Agonist-Induced D2/D3 Receptor Desensitization and Internalization In Vivo with PET/fMRI
Sander, C. Y. M., Hooker, J. M., Catana, C., Rosen, B. R., & Mandeville, J. B. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.296 · Cited by 67
Defining and characterizing drug/compound function
Kenakin, T., & Williams, M. J. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.07.033 · Cited by 69
Evolution of the drug-target residence time model
Copeland, R. A. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1948997 · Cited by 61
Buchwald, P. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00605 · Cited by 69
Ensemble of G Protein-Coupled Receptor Active States
Park, P. S.-H. (2012) · Current Medicinal Chemistry · doi:10.2174/092986712799320619 · Cited by 55
Boran, A. D. W., & Iyengar, R. (2010) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20191 · Cited by 56
Historical evolution of the neurotransmission concept
Lopez-Munoz, F. J., & Álamo, C. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0213-1 · Cited by 51
Inhaled protein/peptide-based therapies for respiratory disease
Fellner, R. C., Terryah, S. T., & Tarran, R. (2016) · Molecular and Cellular Pediatrics · doi:10.1186/s40348-016-0044-8 · Cited by 53
Quantitative structural assessment of graded receptor agonism
Shang, J., Brust, R., Griffin, P. R., Kamenecka, T. M., & Kojetin, D. J. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1909016116 · Cited by 47
Oxytocin Receptor Signaling in Vascular Function and Stroke
McKay, E. C., & Counts, S. (2020) · Frontiers in Neuroscience · doi:10.3389/fnins.2020.574499 · Cited by 46
Wu, Y., Huang, J. L., He, H., Wang, M., Yin, G., Qi, L., He, X., Wang, H., & Wang, K. (2023) · Nano Letters · doi:10.1021/acs.nanolett.2c04657 · Cited by 46
Pharmacological traits of delta opioid receptors: pitfalls or opportunities?
van Rijn, R. M., DeFriel, J. N., & Whistler, J. L. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3129-2 · Cited by 51
Defining the Role of Pharmacology in the Emerging World of Translational Research
Enna, S. J., & Williams, M. J. (2009) · Advances in pharmacology · doi:10.1016/s1054-3589(08)57001-3 · Cited by 49
Onaran, H. O., Rajagopal, S., & Costa, T. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.09.010 · Cited by 46
The fall and rise of pharmacology – (Re-)defining the discipline?
Winquist, R. J., Mullane, K., & Williams, M. J. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.09.011 · Cited by 44
Possible opportunities and challenges for traditional Chinese medicine research in 2035
Huang, N., Huang, W., Wu, J., Long, S., Luo, Y., & Huang, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1426300 · Cited by 37
Design of Recombinant Antibody Microarrays for Cell Surface Membrane Proteomics
Mellby, L. D., Ingvarsson, J., Frendéus, B., Borrebaeck, C. A. K., & Wingren, C. (2007) · Journal of Proteome Research · doi:10.1021/pr070257x · Cited by 36
General Linearized Biexponential Model for QSAR Data Showing Bilinear-Type Distribution
Buchwald, P. (2005) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.20438 · Cited by 37
Molecular Modelling of Drug Targets: The Past, the Present and the Future
Dahl, S. G., & Sylte, I. (2005) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2005.pto960302.x · Cited by 32
Scientific process, pharmacology and drug discovery
Trist, D. G. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.05.008 · Cited by 31
González, D., & Sinha, J. (2021) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1881 · Cited by 31
A single unified model for fitting simple to complex receptor response data
Buchwald, P. (2020) · Scientific Reports · doi:10.1038/s41598-020-70220-w · Cited by 33
Fisher, S. K., & Wonnacott, S. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-374947-5.00013-4 · Cited by 27
Buchwald, P. (2017) · Pharmacology Research & Perspectives · doi:10.1002/prp2.311 · Cited by 26
Biology is more theoretical than physics
Gunawardena, J. (2013) · Molecular Biology of the Cell · doi:10.1091/mbc.e12-03-0227 · Cited by 22
A Pharmacological Perspective on the Study of Taste
Palmer, R. K. (2018) · Pharmacological Reviews · doi:10.1124/pr.118.015974 · Cited by 24
Zhao, X., Han, Q., Na, N., & Ouyang, J. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c03282 · Cited by 21
Neuropeptide PEN and Its Receptor GPR83: Distribution, Signaling, and Regulation
Mack, S. M., Gomes, I., & Devi, L. A. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00559 · Cited by 20
A short history of the rise of the molecular pharmacology of ionotropic drug receptors
Halliwell, R. F. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.03.007 · Cited by 18
Self-citationBuchwald, P. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1541872 · Cited by 16
The manipulability of what? The history of G-protein coupled receptors
Barwich, A., & Bschir, K. (2017) · Biology & Philosophy · doi:10.1007/s10539-017-9608-9 · Cited by 15
Bruns, I. R., Chhum, S., Dinh, A., Doerr, H. W., Dunn, N. R., Ly, Y. T., Mitman, C. L., Rickards, H. D., del Sol, C., Wan, E. W. Y., et al. (2006) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2006.00714.x · Cited by 15
Exogenous Opioids and the Human Endocrine System: An Endocrine Society Scientific Statement
Karavitaki, N., Bettinger, J. J., Biermasz, N., Christ-Crain, M., Gadelha, M. R., Inder, W. J., Tsourdi, E., Wakeman, S. E., & Zatelli, M. (2024) · Endocrine Reviews · doi:10.1210/endrev/bnae023 · Cited by 14
Full and partial agonism of a designed enzyme switch
Budiardjo, S. J., Licknack, T. J., Cory, M. B., Kapros, D., Roy, A., Lovell, S., Douglas, J., & Karanicolas, J. (2016) · ACS Synthetic Biology · doi:10.1021/acssynbio.6b00097 · Cited by 13
Black, J. W. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01019.x · Cited by 13
Zhang, W., Tao, W., Zhou, J., Wu, C., Long, F., Shen, H., Zhu, H., Mao, Q., Xu, J., Li, S., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02084-3 · Cited by 12
World Conference on Dosing of Antiinfectives:‘Dosing the Magic Bullets’
Sörgel, F. (2004) · Chemotherapy · doi:10.1159/000077276 · Cited by 11
DNA logic gate for cancer cells identification, detection, and modulation of cell–cell interactions
Ling, P., Xu, W., Qiao, Y., Song, D., Tang, C., Wang, L., & Yang, P. (2024) · Microchemical Journal · doi:10.1016/j.microc.2024.111840 · Cited by 7
Yang, H., Micovic, N., Monaghan, J. R., & Clark, H. A. (2022) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.2c00446 · Cited by 7
Banba, S. (2021) · Journal of Pesticide Science · doi:10.1584/jpestics.j21-01 · Cited by 7
Fang, X., & Chen, X. (2016) · Science China Life Sciences · doi:10.1007/s11427-016-0254-2 · Cited by 7
Neurochemistry of the Central Nervous System
Ascenzi, B. M., Myers, M. W., & Buccilli, B. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-822404-5.00016-4 · Cited by 7
Rational Design of DNA Nanostructures as TLR9 Agonists
Chen, C., Tian, C., Jin, Z., Wen, Y., Xia, X., Ren, Q., Huang, C. Z., & Zuo, H. (2025) · Biomacromolecules · doi:10.1021/acs.biomac.5c00919 · Cited by 6
Palacios, D. S. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c01491 · Cited by 6
Jr.Devi, G. (2013) · Colloquium Series on Neuropeptides · doi:10.4199/c00082ed1v01y201304npe004 · Cited by 6
Minding the gap: discovering the phenomenon of chemical transmission in the nervous system
Bechtel, W. (2023) · History & Philosophy of the Life Sciences · doi:10.1007/s40656-023-00591-6 · Cited by 6
Prüll, C. (2006) · Bulletin of the history of medicine · doi:10.1353/bhm.2006.0111 · Cited by 5
Self-citationNetwork Medicine: Methods and Applications
Alam, A., Yildirim, O., Siddiqui, M. F., Imam, N., & Bay, S. (2023) · Springer eBooks · doi:10.1007/978-981-99-4242-8_5 · Cited by 4
Palacios, J. M., & Mengod, G. (2017) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2017.07.007 · Cited by 4
Attractor – a new turning point in drug discovery
Hou, X., Li, M., Jia, C. M., Zhang, X.-B., & Wang, Y. (2019) · Drug Design Development and Therapy · doi:10.2147/dddt.s216397 · Cited by 4
Nicotinic acetylcholine receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
Gotti, C., Marks, M. J., Millar, N. S., & Wonnacott, S. (2019) · IUPHAR/BPS Guide to Pharmacology CITE · doi:10.2218/gtopdb/f76/2019.4 · Cited by 4
Chandrasekaran, B., Al-Joubi, H., Samarneh, S., Kassab, G. H., Deb, P. K., Kumar, P., Al-Jaidi, B. A., Thaher, Y. A., & Bataineh, Y. A. (2020) · Springer eBooks · doi:10.1007/978-981-15-3556-7_2 · Cited by 4
Simón, J. (2011) · Elsevier eBooks · doi:10.1016/b978-0-444-51675-6.50033-5 · Cited by 4
Non-Specificity of Drug-Target Interactions – Consequences for Drug Discovery
Maggiora, G. M., & Gokhale, V. M. (2016) · ACS symposium series · doi:10.1021/bk-2016-1222.ch007 · Cited by 5
Introduction: The Case for Polypharmacology
Hopkins, A. L. (2012) · Wiley eBooks · doi:10.1002/9781118098141.ch · Cited by 6
Kenakin, T. (2006) · Elsevier eBooks · doi:10.1016/b978-012370599-0/50002-2 · Cited by 3
Kenakin, T. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374585-9.00001-3 · Cited by 3
Definiendo términos farmacológicos basados en las interacciones ligando receptor
Nájera, N., Ceballos, G. M., González, C., Hidalgo, I., Ortíz-Flores, M., & Portilla-Martínez, A. (2020) · Cardiovascular and Metabolic Science · doi:10.35366/95585 · Cited by 3
Fifty years of Biochemical Pharmacology: The discipline and the journal
Enna, S. J., FEUERSTEIN, G. Z., Piette, J. G., & Williams, M. J. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.03.024 · Cited by 6
Kramer, I. M. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-394803-8.00001-2 · Cited by 3
Advances in structure-based virtual screening for drug discovery
Olubiyi, O. O., Samantray, S., & Illig, A.-M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90264-9.00024-6 · Cited by 4
Buchwald, P. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1274065 · Cited by 3
Toxicodynamics: How Chemicals Harm Cells
Burcham, P. C. (2013) · Springer eBooks · doi:10.1007/978-1-4471-5553-9_4 · Cited by 3
Welcome, M. O. (2018) · Springer eBooks · doi:10.1007/978-3-319-91056-7_11 · Cited by 3
Geoffrey Burnstock – An accidental pharmacologist
Virgilio, F. D., Jacobson, K. A., & Williams, M. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.114300 · Cited by 3
Bouvier, M. (2012) · médecine/sciences · doi:10.1051/medsci/20122810002 · Cited by 3
The Molecular Pharmacology of Pateamine A
Matthews, J. H. (2010) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.16992643.v1 · Cited by 5
Wu, Y., Yin, G., Zhang, Q., Qi, L., Zhang, B., Chen, M., Liu, L., Zhou, Y., He, L., Wang, H.-H., et al. (2026) · Journal of the American Chemical Society · doi:10.1021/jacs.6c05492 · Cited by 2
An Historical Introduction to Biased Signaling
Arey, B. J. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-411460-9.00001-x · Cited by 2
Kenakin, T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813957-8.00001-1 · Cited by 2
Fall and rise of behavioural pharmacology
de Graaf, J. S. (2006) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2006.06.007 · Cited by 2
Mixed-mechanism analgesics for mixed pain
Raffa, R. B. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1717207 · Cited by 1
The Hill–Langmuir Equation Governs Drug–Target Binding Kinetics for Pulsed Drug Delivery
Shi, X. Q. (2025) · Fundamental and Clinical Pharmacology · doi:10.1111/fcp.70069 · Cited by 1
Mechanism of Drug Action: Basic Concepts
Bodor, N. S., & Buchwald, P. (2012) · Wiley eBooks · doi:10.1002/9781118407738.ch2 · Cited by 1
De las cadenas laterales a la radioterapia de diana
Zorrilla, J. M., Cruz, M. P.-M., & Arencibia, J. C. (2016) · Cited by 1
Mechanisms of Cellular Signal Transduction
Neubig, R. R., Boyd, J. W., Mouch, J. A., & Prince, N. (2019) · Wiley eBooks · doi:10.1002/9781119060208.ch2 · Cited by 3
Kenakin, T. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-407663-1.00001-6 · Cited by 1
Breinbauer, R., Hillisch, A., & Waldmann, H. (2007) · Wiley eBooks · doi:10.1002/9783527619375.ch7a · Cited by 1
Decoding Signals with Chemical Biology
Kiessling, L. L. (2010) · ACS Chemical Biology · doi:10.1021/cb100006u · Cited by 1
Modulation of the M2 muscarinic cholinergic receptor by cholesterol.
Colozo, A. T. (2009) · TSpace (University of Toronto) · Cited by 1
Receptor Targets in Drug Discovery
Duzic, E., Marino, M. J., & Williams, M. J. (2010) · Wiley eBooks · doi:10.1002/0471266949.bmc029.pub2 · Cited by 1
Integration of PBPK and Pharmacodynamics
Peters, S. A. (2012) · Wiley eBooks · doi:10.1002/9781118140291.ch13
British Pharmacological Society, 5th Focused Meeting on Cell Signalling: Matters arising …
Willars, G. B., Tobin, A. B., & Challiss, R. A. J. (2015) · British Journal of Pharmacology · doi:10.1111/bph.13171
Metadata
- Authors
- Maehle, A.-H., Prüll, C.-R., & Halliwell, R. F.
- Affiliations
- Durham University (GB)
- University of the Pacific (US)
- Corresponding author
- Halliwell, Robert F.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2002-08
- Volume
- 1
- Issue
- 8
- Pages
- 637-641
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1530802552
- Semantic Scholar
- e915b6c25705504f0cd8c2c6bd29ce17e41d03f3
- Cited by
- 128
- References
- 47
- Citations by year
- 2026: 6 · 2025: 5 · 2024: 7 · 2023: 5 · 2022: 5 · 2021: 7 · 2020: 8 · 2019: 8 · 2018: 3 · 2017: 7 · 2016: 6 · 2015: 3 · 2014: 4 · 2013: 11 · 2012: 7
- FWCI
- 0.41
- Type
- journal article
- Language
- en
- Open access
- Licence
- cc-by
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Scholarly Commons (University of the Pacific) (submittedVersion)
- Durham Research Online (Durham University) (submittedVersion, cc-by)
- Funders
- Wellcome Trust
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Historical Medical Research and Treatments
- Social Sciences › Arts and Humanities › History and Philosophy of Science › History of Science and Medicine
- Social Sciences › Arts and Humanities › History › Medical History and Innovations
- Keywords
- Paul Ehrlich, history of pharmacology, drug action, neurotransmitter receptors, history of medicine
- MeSH terms
- Animals, Humans, Receptors, Drug, History, 19th Century, History, 20th Century
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.